Jonathan Peacock

Biography

Jonathan has 35 years’ global experience in operations, strategy and business development and extensive expertise within the Biopharma industry. Jonathan is the former CFO of Amgen Inc based in California, USA and prior to that was the CFO of the Pharmaceuticals Division of Novartis AG, based in Switzerland. During Jonathan’s tenure as CFO at Amgen Inc the stock price increased by approximately 125% and at Novartis operating profits increased by over 40%. He has raised over $20 billion in new capital and throughout his career has been engaged in business development and mergers and acquisitions on both the buy-side and sell-side, globally. Before joining the pharmaceutical industry, Jonathan was a partner at McKinsey & Company where he was co-head of the European Corporate Finance practice. Jonathan was also a partner at PricewaterhouseCoopers in London and New York. Jonathan is currently Chairman of Bellerophon Therapeutics and is a non-executive director of Kite Pharma, both of which are listed on NASDAQ. He has a Masters degree in Economics from the University of St Andrews in Scotland.

Research Interest

 Clinical Sciences.